159 related articles for article (PubMed ID: 38157196)
1. Multi-omics joint analysis revealed the metabolic profile of retroperitoneal liposarcoma.
Xie F; Niu Y; Lian L; Wang Y; Zhuang A; Yan G; Ren Y; Chen X; Xiao M; Li X; Xi Z; Zhang G; Qin D; Yang K; Zheng Z; Zhang Q; Xia X; Li P; Gu L; Wu T; Luo C; Lin SH; Li W
Front Med; 2024 Apr; 18(2):375-393. PubMed ID: 38157196
[TBL] [Abstract][Full Text] [Related]
2. Establishment and evaluation of retroperitoneal liposarcoma patient-derived xenograft models: an ideal model for preclinical study.
Xu C; Yan L; An Q; Zhang S; Guan X; Wang Z; Lv A; Liu D; Liu F; Dong B; Zhao M; Tian X; Hao C
Int J Med Sci; 2022; 19(8):1241-1253. PubMed ID: 35928724
[TBL] [Abstract][Full Text] [Related]
3. Identification of TYMS as a promoting factor of retroperitoneal liposarcoma progression: Bioinformatics analysis and biological evidence.
Zhang S; Yan L; Cui C; Wang Z; Wu J; Zhao M; Dong B; Guan X; Tian X; Hao C
Oncol Rep; 2020 Aug; 44(2):565-576. PubMed ID: 32627015
[TBL] [Abstract][Full Text] [Related]
4. Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic sarcoma.
Chung L; Lau SK; Jiang Z; Loera S; Bedel V; Ji J; Weiss LM; Chu PG
Am J Surg Pathol; 2009 Nov; 33(11):1594-600. PubMed ID: 19574885
[TBL] [Abstract][Full Text] [Related]
5. Expression and function of Siglec-15 in RLPS and its correlation with PD-L1: Bioinformatics Analysis and Clinicopathological Evidence.
Cui L; Tian X; Yan L; Guan X; Dong B; Zhao M; Lv A; Liu D; Wu J; Hao C
Int J Med Sci; 2022; 19(13):1977-1988. PubMed ID: 36438917
[No Abstract] [Full Text] [Related]
6. Tsp2 Facilitates Tumor-associated Fibroblasts Formation and Promotes Tumor Progression in Retroperitoneal Liposarcoma.
Xu C; Yan L; Guan X; Wang Z; Wu J; Lv A; Liu D; Liu F; Dong B; Zhao M; Jia L; Tian X; Hao C
Int J Biol Sci; 2022; 18(13):5038-5055. PubMed ID: 35982904
[TBL] [Abstract][Full Text] [Related]
7. Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma.
Coindre JM; Mariani O; Chibon F; Mairal A; De Saint Aubain Somerhausen N; Favre-Guillevin E; Bui NB; Stoeckle E; Hostein I; Aurias A
Mod Pathol; 2003 Mar; 16(3):256-62. PubMed ID: 12640106
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive immune characterization and T-cell receptor repertoire heterogeneity of retroperitoneal liposarcoma.
Yan L; Wang Z; Cui C; Guan X; Dong B; Zhao M; Wu J; Tian X; Hao C
Cancer Sci; 2019 Oct; 110(10):3038-3048. PubMed ID: 31385405
[TBL] [Abstract][Full Text] [Related]
9. Comparison between retroperitoneal leiomyosarcoma and dedifferentiated liposarcoma.
Ishii T; Kohashi K; Ootsuka H; Iura K; Maekawa A; Yamada Y; Bekki H; Yoshimoto M; Yamamoto H; Iwamoto Y; Oda Y
Pathol Res Pract; 2017 Jun; 213(6):634-638. PubMed ID: 28552535
[TBL] [Abstract][Full Text] [Related]
10. Immunostaining for peroxisome proliferator gamma distinguishes dedifferentiated liposarcoma from other retroperitoneal sarcomas.
Horvai AE; Schaefer JT; Nakakura EK; O'Donnell RJ
Mod Pathol; 2008 May; 21(5):517-24. PubMed ID: 18204431
[TBL] [Abstract][Full Text] [Related]
11. Similarity in genetic alterations between paired well-differentiated and dedifferentiated components of dedifferentiated liposarcoma.
Horvai AE; DeVries S; Roy R; O'Donnell RJ; Waldman F
Mod Pathol; 2009 Nov; 22(11):1477-88. PubMed ID: 19734852
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity.
Coindre JM; Hostein I; Maire G; Derré J; Guillou L; Leroux A; Ghnassia JP; Collin F; Pedeutour F; Aurias A
J Pathol; 2004 Jul; 203(3):822-30. PubMed ID: 15221942
[TBL] [Abstract][Full Text] [Related]
13. Well-differentiated liposarcoma with low-grade osteosarcomatous component: an underrecognized variant.
Yoshida A; Ushiku T; Motoi T; Shibata T; Fukayama M; Tsuda H
Am J Surg Pathol; 2010 Sep; 34(9):1361-6. PubMed ID: 20697254
[TBL] [Abstract][Full Text] [Related]
14. Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysis.
de Vreeze RS; de Jong D; Tielen IH; Ruijter HJ; Nederlof PM; Haas RL; van Coevorden F
Mod Pathol; 2009 Feb; 22(2):223-31. PubMed ID: 18820664
[TBL] [Abstract][Full Text] [Related]
15. TNM classification of malignant tumors: Eighth edition for retroperitoneal liposarcoma. Ways to improve.
Nered SN; Volkov AY; Kozlov NA; Stilidi IS; Arhiri PP
Asia Pac J Clin Oncol; 2023 Oct; 19(5):e267-e272. PubMed ID: 36385584
[TBL] [Abstract][Full Text] [Related]
16. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms.
Pilotti S; Della Torre G; Lavarino C; Di Palma S; Sozzi G; Minoletti F; Rao S; Pasquini G; Azzarelli A; Rilke F; Pierotti MA
J Pathol; 1997 Jan; 181(1):14-24. PubMed ID: 9071998
[TBL] [Abstract][Full Text] [Related]
17. [Retroperitoneal dedifferentiated liposarcoma with rhabdomyoblastic differentiation: a clinicopathological analysis].
Liu L; Wang LH; Ren YB; Rao XS; Yang SM
Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):94-98. PubMed ID: 29429159
[No Abstract] [Full Text] [Related]
18. A review of retroperitoneal liposarcoma genomics.
Tyler R; Wanigasooriya K; Taniere P; Almond M; Ford S; Desai A; Beggs A
Cancer Treat Rev; 2020 Jun; 86():102013. PubMed ID: 32278233
[TBL] [Abstract][Full Text] [Related]
19. [Advances in the etiology of retroperitoneal liposarcoma].
Yuan ZQ; Liu YB
Zhonghua Wai Ke Za Zhi; 2024 May; 62(5):472-476. PubMed ID: 38548619
[TBL] [Abstract][Full Text] [Related]
20. Giant retroperitoneal well-differentiated liposarcoma presenting in emergency with intestinal occlusion: Case report and review of the literature.
Evola G; Schillaci R; Reina M; Caruso G; D'Angelo M; Reina GA
Int J Surg Case Rep; 2022 Jun; 95():107152. PubMed ID: 35580411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
